Cargando…
A clinical decision aid for the selection of antithrombotic therapy for the prevention of stroke due to atrial fibrillation
AIMS: The availability of new antithrombotic agents, each with a unique efficacy and bleeding profile, has introduced a considerable amount of clinical uncertainty with physicians. We have developed a clinical decision aid in order to assist clinicians in determining an optimal antithrombotic regime...
Autores principales: | LaHaye, Stephen Andrew, Gibbens, Sabra Lynn, Ball, David Gerald Andrew, Day, Andrew George, Olesen, Jonas Bjerring, Skanes, Allan Cameron |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432235/ https://www.ncbi.nlm.nih.gov/pubmed/22752615 http://dx.doi.org/10.1093/eurheartj/ehs167 |
Ejemplares similares
-
Prestroke and Poststroke Antithrombotic Therapy in Patients With Atrial Fibrillation: Results From a Nationwide Cohort
por: Gundlund, Anna, et al.
Publicado: (2018) -
Novel Anti-arrhythmic Medications in the Treatment of Atrial Fibrillation
por: Saklani, Pradyot, et al.
Publicado: (2012) -
Initiation and Persistence with Warfarin Therapy in Atrial Fibrillation According to Ethnicity
por: Hansen, Carolina Malta, et al.
Publicado: (2012) -
A randomized trial to assess the impact of an antithrombotic decision aid in patients with nonvalvular atrial fibrillation: the DAAFI trial protocol [ISRCTN14429643]
por: McAlister, Finlay A, et al.
Publicado: (2004) -
The use of antithrombotics in patients presenting with stroke and atrial fibrillation
por: Burgess, Carl, et al.
Publicado: (2007)